Compound ID | 1409
MEDI6389 (MEDI4893*, SAR114 and SAN481)
Class: Antibody (monoclonal antibody [mAb])
| Spectrum of activity: | Gram-positive |
| Details of activity: | S.aureus |
| Institute where first reported: | AstraZeneca, UK |
| Year first mentioned: | 2019 |
| Highest developmental phase: | Preclinical |
| External links: | |
| Citation: | https://aac.asm.org/content/63/8/e00346-19 |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.